Of the 38 genes identified, the gene with the strongest association with outcome (using a combined readout of tumor reduction and OS) was UBA7, which encodes an E1-like ubiquitin-activating enzyme involved in conjugation of ISG15 to proteins (ISGylation), a key process in the response to type-I IFN.34 This evidence concerns the gene UBA7 and neoplasm.